Popular Weight-Loss Drugs Pose Serious Risks for Pregnant Women — But Warnings Are Buried

The U.S. Food and Drug Administration warns that Ozempic — approved for diabetes but taken off-label for weight loss — and Wegovy should be discontinued at least two months prior to pregnancy, but those warnings are buried and long-term testing won’t be completed for years.